Hologic, Inc.’s Cynosure division announced today the North American launch of the FDA-cleared TempSure ™ Surgical RF technology, a new offering of the TempSure ™ radiofrequency (RF) platform that ...

SculpSure submental application now FDA-cleared for patients with BMI up to 49, the highest BMI clearance on the market MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic’s (Nasdaq: HOLX) Cynosure division ...

MARLBOROUGH, Mass., July 11, 2018 /CNW/ -- Hologic's (Nasdaq: HOLX) Cynosure division announced today the North American launch of TempSure™ Vitalia, an FDA-cleared and Health Canada-approved advanced ...

Leading player in the field of women's health, Hologic, Inc. HOLX recently announced that its Cynosure division has launched the FDA-approved TempSure Surgical RF technology in North America. Notably, ...

Hologic’s Cynosure division announced today the launch of two new products that expand the Company’s growing portfolio of innovative aesthetic treatments — the TempSure ® Firm handpiece and a petite ...

Marlborough medical device maker Hologic is expecting revenues from subsidiary Cynosure to be about $15 million less after it halted sales of a device due to a government warning. Westford-based ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Cynosure, a division of Hologic, has launched StimSure ®, a non-invasive electromagnetic technology to build and tone muscle in the abdomen, buttocks and thighs, ...